JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms

被引:291
作者
David, JP
Sabapathy, K
Hoffmann, O
Idarraga, MH
Wagner, EF
机构
[1] Res Inst Mol Pathol, IMP, A-1030 Vienna, Austria
[2] Pharm Zentrum, Inst Pharmakol & Toxikol, A-1090 Vienna, Austria
关键词
Jun-N-terminal kinase; c-Jun; osteoclasts; RANKL; apoptosis;
D O I
10.1242/jcs.00082
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Phosphorylation of the N-terminal domain of Jun by the Jun kinases (JNKs) modulates the transcriptional activity of AP-1, a dimeric transcription factor typically composed of c-Jun and c-Fos, the latter being essential for osteoclast differentiation. Using mice lacking JNK1 or JNK2, we demonstrate that JNK1, but not JNK2, is specifically activated by the osteoclast-differentiating factor RANKL. Activation of JNKI, but not JNK2, is required for efficient osteoclastogenesis from bone marrow monocytes.(BMMs). JNK1 protects BMMs from RANKL-induced apoptosis during differentiation. In addition, BMMs from mice carrying a mutant of c-Jun phosphorylation sites (junAA/JunAA), as well as cells lacking either c-Jun or JunD, which is another JNK substrate, revealed that c-Jun phosphorylation and c-Jun itself, but not JunD, are essential for efficient osteoclastogenesis. Moreover, JNK1-dependent c-Jun phosphorylation in response to RANKL is not involved in the anti-apoptotic function of JNK1. Thus, these data provide genetic evidence that JNK1 activation modulates osteoclastogenesis through both c-jun-phosphorylation-dependent and -independent mechanisms.
引用
收藏
页码:4317 / 4325
页数:9
相关论文
共 39 条
[1]
Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307
[2]
Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor [J].
AbuAmer, Y ;
Ross, FP ;
Edwards, J ;
Teitelbaum, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1557-1565
[3]
c-Jun NH2-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8+ T cell-mediated antiviral immunity [J].
Arbour, N ;
Naniche, D ;
Homann, D ;
Davis, RJ ;
Flavell, RA ;
Oldstone, MBA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) :801-810
[4]
Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation [J].
Behrens, A ;
Jochum, W ;
Sibilia, M ;
Wagner, EF .
ONCOGENE, 2000, 19 (22) :2657-2663
[5]
Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver [J].
Behrens, A ;
Sibilia, M ;
David, JP ;
Möhle-Steinlein, U ;
Tronche, F ;
Schütz, G ;
Wagner, EF .
EMBO JOURNAL, 2002, 21 (07) :1782-1790
[6]
Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT) [J].
Behrens, A ;
Sabapathy, K ;
Graef, I ;
Cleary, M ;
Crabtree, GR ;
Wagner, EF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1769-1774
[7]
Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation [J].
Behrens, A ;
Sibilia, M ;
Wagner, EF .
NATURE GENETICS, 1999, 21 (03) :326-329
[8]
Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1) [J].
Brown, KD ;
Hostager, BS ;
Bishop, GA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) :943-954
[9]
Chan FKM, 2000, EUR J IMMUNOL, V30, P652
[10]
Mammalian MAP kinase signalling cascades [J].
Chang, LF ;
Karin, M .
NATURE, 2001, 410 (6824) :37-40